RapidShock Post-Approval Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2756 participants.
Also called NCT04014842
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,756 participants
- Sponsor
- Registry
-
NCT04014842
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04014842. Allocation not applicable; no masking; primary purpose treatment. Start 2019-02-26 (actual); primary completion 2023-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RapidShock Post-Approval Study
- Condition
- Cardiac Arrest
- Intervention (Device)
- RapidShock
- Lead sponsor
- Zoll Medical Corporation
Record details
- Record id
cardio:ct-nct04014842- Content hash
a5babd5bc1d938746eb8e8e58360c39497c9a5b387e7c91af2771a61836edd11